MOPP/EBV/CAD hybrid chemotherapy with or without limited radiotherapy in advanced or unfavorably presenting Hodgkin's disease: a report from the Italian Lymphoma Study Group.
暂无分享,去创建一个
P. Gobbi | L. Cavanna | E. Iannitto | M. Federico | G. Grignani | F. Narni | P. Avanzini | N. Di Renzo | C. Pieresca | G. Partesotti